MEK1 plays contrary stage-specific roles in skeletal myogenic differentiation

Area of Science:

• Molecular Biology
• Cell Signaling
• Muscle Development

Background:

• Extracellular signal-regulated kinase (ERK) signaling has contradictory roles in skeletal myogenesis.
• This study investigates the stage-specific functions of mitogen-activated protein kinase kinase 1 (MEK1) in resolving these discrepancies.

Purpose of the Study:

• To elucidate the stage-specific roles of MEK1 in C2C12 myogenesis.
• To determine the relationship between MEK1 activation timing and its impact on muscle differentiation.

Main Methods:

• Utilized MEK-specific inhibitors (PD184352, U0126) and ERK-specific inhibitors (FR180204, ERK inhibitor I) on differentiating C2C12 cells.
• Employed a Tet-Off expression system to control the timing of activated MEK1 expression.
• Assessed myogenic differentiation markers, including MHC protein levels and MCK promoter activity, and Id2 protein levels.

Main Results:

• MEK1 activity is low early in differentiation and peaks mid-stage.
• Inhibiting MEK1 early reduces differentiation; high MEK1 activity mid-stage is crucial for myogenesis.
• Sustained or early induction of active MEK1 inhibits differentiation, while later induction stimulates it, affecting Id2 protein levels differentially.

Conclusions:

• MEK1 exhibits stage-specific and opposing roles in myogenesis.
• Mid-stage MEK1 activation promotes muscle differentiation independently of ERK signaling.
• The timing of MEK1 activation is critical for its functional outcome in skeletal muscle development.